Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New strategies in the evaluation of allergenic molecules

03.02.2006


The Dermatochemistry laboratory of the University Louis Pasteur’s Institute of Chemistry (Strasbourg 1) becomes a partner in the integrated European research project Sens-it-iv whose aim is to develop alternative methods to animal testing in the area of allergy.



Even though animal experimentation remains, for the moment, the most reliable way of testing the allergenic potential of a chemical substance, the wish of the European Union is to gradually reduce the number of animals used in toxicity tests. In 1996, a EU Directive on the protection of animals used for experimental purposes prohibits their use when valid, alternative testing methods exist. However, if the REACH -Registration, evaluation and authorisation of chemicals – legislation is instituted, 3000 chemical products marketed in Europe will have to be evaluated for their toxicological properties. (The objective of REACH is to ask the manufacturers to prove that the products they put on the market are harmless). In this context, it is of utmost importance therefore, to develop alternative strategies based on cell or tissue culture or computer modelling.

The objective of the Sens-it-iv project, which brings together 28 universities, institutes, companies and organisations, is to develop alternative in vitro methods that are able to evaluate the allergenic potential of a chemical substance without having to resort to animal testing. The ULP dermatochemistry laboratory, directed by Professor Jean-Pierre Lepoittevin, is the only chemistry laboratory taking part in the Sens-it-iv project. Its role (dedicated mostly to organic chemistry) will be to evaluate the chemical reactivity of different molecules and to study the reaction mechanisms between allergens (foreign substances capable of triggering an allergic reaction in the body) and cutaneous biomolecules (skin proteins). The results from each partnering laboratory will be gathered and pooled together in order to determine the structure and action of each chemical substance using the technique of bioinformatic simulation to ascertain their toxicity without using the animal experimentation model. The development of these alternative research methods concerns both contact allergens and respiratory allergens. Sens-it-iv takes on its full meaning given the increasing incidence of allergies observed in the European population.


The Sens-it-iv project is involved in the 6th EU Framework Programme for Research and Technological Development (FPRTD) and will be financed to the sum of 11 millions Euros for the period 2006-2010.

Maria Isabel Pellon Zarragoitia | alfa
Further information:
http://www-ulp.u-strasbg.fr

More articles from Life Sciences:

nachricht Decoding the genome's cryptic language
27.02.2017 | University of California - San Diego

nachricht New risk factors for anxiety disorders
24.02.2017 | Julius-Maximilians-Universität Würzburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Safe glide at total engine failure with ELA-inside

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

New pop-up strategy inspired by cuts, not folds

27.02.2017 | Materials Sciences

Sandia uses confined nanoparticles to improve hydrogen storage materials performance

27.02.2017 | Interdisciplinary Research

Decoding the genome's cryptic language

27.02.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>